Updated:
Biocon Limited
Biocon Limited is a other based in Bangalore, founded 1978; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts...
Biocon Limited
Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs
General information
Firm type
other
Year founded
1978
Location
Region
Asia
Country
India
City
Bangalore
Corporate office
Bangalore, India
Principals
Kiran Mazumdar-Shaw
Executive Chairperson
Sector focus
Frequently asked questions
Who leads Biocon's strategic and investment decisions?
Kiran Mazumdar-Shaw serves as Executive Chairperson and is the founder. The Board of Directors includes independent and executive members. The Key Management Team and Executive Committee drive operational decisions across the generics, biosimilars, and research services businesses.
How is Biocon structured between its operating businesses and its R&D arm?
Biocon operates through three primary businesses: Generics (complex APIs and formulations), Biosimilars (via Biocon Biologics), and Research Services (via Syngene, which is a separately listed company). Novel Biologics is an early-stage pipeline within Biocon.
Does Biocon rely on partnerships for commercializing its products globally?
Yes. In select markets like China, Biocon has licensed products to China Medical System (CMS). In Brazil it pursues a B2B partnering model. In the US and parts of Europe (UK, Germany, Netherlands, Italy) it maintains a direct commercial presence.
What is Biocon's approach to pricing and access?
Biocon's strategy centers on affordability through vertical integration, scale, and efficiency. The company aims to deliver biosimilars at 15–30% of the originator's price, particularly targeting underserved populations in developing countries.
What is Biocon's relationship with the Biocon Foundation?
The Biocon Foundation is Biocon's philanthropic arm focused on health, education, and social development in India. It is funded by Biocon and partners with government agencies, NGOs, and academic institutions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: